Preventive Efficacy and Safety of Rebamipide in Nonsteroidal Anti-Inflammatory Drug-Induced Mucosal Toxicity

BACKGROUND/AIMS: The use of proton pump inhibitors or misoprostol is known to prevent the gastrointestinal complications of nonsteroidal anti-inflammatory drugs (NSAIDs). Rebamipide is known to increase the mucosal generation of prostaglandins and to eliminate free oxygen radicals, thus enhancing th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jeong Ho, Park, Soo-Heon, Cho, Chul-Soo, Lee, Soo Teik, Yoo, Wan-Hee, Kim, Sung Kook, Kang, Young Mo, Rew, Jong Sun, Park, Yong-Wook, Lee, Soo Kon, Lee, Yong Chan, Park, Won, Lee, Don-Haeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Gut and Liver 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113040/
https://www.ncbi.nlm.nih.gov/pubmed/25071901
http://dx.doi.org/10.5009/gnl.2014.8.4.371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113040/
https://www.ncbi.nlm.nih.gov/pubmed/25071901
http://dx.doi.org/10.5009/gnl.2014.8.4.371

Ejemplares similares